Minerva Neurosciences | L'Utile Ante Imposte

Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Adma Biologics USD 2.56M 9.35M 2023-09
Cipla INR 15.94B 2.2B 2023-09
Clal Biotechnology ILS 104.72M 129.66M 2020-12
Compugen USD -9852000 527K 2023-09
CSL USD 699.7M 1.26B 2023-06
Dynavax Technologies USD 996K 13.15M 2023-12
Eli Lilly USD 2.59B 2.27B 2023-12
GlaxoSmithKline GBP 2.62B 600M 2023-09
Halozyme Therapeutics USD 122.27M 894K 2023-09
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pfizer USD -1250000000 5.38B 2023-09
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 3.96B 1.2B 2023-09
Takeda JPY -95980000000 231.01B 2023-09



Minerva Neurosciences L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.